Koen Van Laere Selected Research

Koen Van Laere Research Topics

Disease

27	Alzheimer Disease (Alzheimer's Disease) 10/2023 - 03/2009
21	Parkinson Disease (Parkinson's Disease) 01/2022 - 01/2003
12	Cognitive Dysfunction 04/2024 - 08/2007
11	Neuroinflammatory Diseases 02/2024 - 08/2011
10	Epilepsy (Aura) 04/2022 - 12/2003
9	Inflammation (Inflammations) 11/2023 - 08/2013
8	Pain (Aches) 02/2022 - 04/2010
8	Parkinsonian Disorders (Parkinsonism) 10/2021 - 07/2008
7	Huntington Disease (Huntington's Disease) 01/2023 - 09/2010
6	Neoplasms (Cancer) 04/2022 - 12/2013
6	Seizures (Absence Seizure) 01/2020 - 06/2006
6	Schizophrenia (Dementia Praecox) 01/2017 - 01/2013
5	Mental Disorders (Mental Disorder) 02/2024 - 05/2010
5	Stroke (Strokes) 01/2022 - 01/2010
5	Dementia (Dementias) 01/2022 - 01/2013
4	Neuroendocrine Tumors (Neuroendocrine Tumor) 06/2023 - 06/2020
4	Disease Progression 01/2023 - 06/2006
4	Alcoholism (Alcohol Abuse) 01/2022 - 02/2014
4	Amyloid Plaque 01/2022 - 12/2013
4	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 11/2020 - 08/2016
4	Psychotic Disorders (Schizoaffective Disorder) 02/2015 - 01/2013
4	Obesity 08/2014 - 01/2008
4	Anorexia Nervosa 02/2014 - 02/2003
4	Temporal Lobe Epilepsy 04/2011 - 06/2007
3	Ischemic Stroke 01/2023 - 01/2010
3	Giant Cell Arteritis (Horton Disease) 01/2023 - 02/2020
3	Atrophy 01/2022 - 01/2017
3	Neoplasm Metastasis (Metastasis) 10/2020 - 08/2013
3	Primary Progressive Aphasia 01/2020 - 01/2017
3	Frontotemporal Dementia (Semantic Dementia) 01/2020 - 01/2020
3	Dyskinesias (Dyskinesia) 01/2018 - 07/2008
3	Neurogenic Inflammation 11/2013 - 01/2013
3	Drug Resistant Epilepsy 07/2008 - 12/2005
2	Polymyalgia Rheumatica (Rhizomelic Pseudopolyarthritis) 01/2023 - 01/2022
2	Breast Neoplasms (Breast Cancer) 04/2022 - 01/2022
2	Cerebral Amyloid Angiopathy (Congophilic Angiopathy) 01/2022 - 01/2021
2	Siderosis 01/2022 - 04/2011
2	Tauopathies 01/2020 - 12/2018
2	Carcinoma (Carcinomatosis) 01/2020 - 08/2013
2	Neurodegenerative Diseases (Neurodegenerative Disease) 09/2019 - 12/2018
2	Anorexia 02/2014 - 10/2011
2	Feeding and Eating Disorders (Eating Disorder) 02/2014 - 10/2011
2	Central Nervous System Diseases (CNS Diseases) 07/2011 - 08/2010
2	Multiple System Atrophy 04/2010 - 01/2003
2	Status Epilepticus (Complex Partial Status Epilepticus) 05/2009 - 06/2007
2	Infections 03/2004 - 02/2004

Drug/Important Bio-Agent (IBA)

23	Amyloid (Amyloid Fibrils)IBA 04/2024 - 08/2007
17	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 02/2024 - 01/2005
13	Glucose (Dextrose)FDA LinkGeneric 02/2024 - 07/2008
13	Cannabinoid Receptors (Cannabinoid Receptor)IBA 10/2019 - 06/2008
12	Biomarkers (Surrogate Marker)IBA 10/2023 - 08/2009
10	EndocannabinoidsIBA 01/2016 - 03/2008
7	LigandsIBA 11/2023 - 08/2011
6	Proteins (Proteins, Gene)FDA Link 11/2023 - 01/2019
6	Phosphoric Diester Hydrolases (Phosphodiesterases)IBA 01/2022 - 01/2013
6	Dopamine (Intropin)FDA LinkGeneric 01/2022 - 04/2010
6	Dopamine Plasma Membrane Transport Proteins (Dopamine Transporter)IBA 01/2020 - 02/2010
5	N,N- diethyl- 2- (2- (4- (2- fluoroethoxy)phenyl)- 5,7- dimethylpyrazolo(1,5- a)pyrimidin- 3- yl)acetamideIBA 04/2022 - 10/2015
5	2- carbomethoxy- 8- (3- fluoropropyl)- 3- (4- iodophenyl)tropaneIBA 01/2021 - 07/2008
5	Oxidopamine (6 Hydroxydopamine)IBA 01/2018 - 11/2006
5	CB1 Cannabinoid Receptor (CB1 Receptor)IBA 02/2014 - 02/2010
4	Metabotropic Glutamate 5 ReceptorIBA 04/2024 - 12/2015
4	Somatostatin Receptors (Somatostatin Receptor)IBA 01/2023 - 06/2020
4	Amyloid beta-PeptidesIBA 01/2022 - 03/2009
4	Purinergic P2X7 ReceptorsIBA 01/2020 - 01/2016
4	CannabinoidsIBA 11/2016 - 01/2008
3	EnzymesIBA 01/2022 - 01/2013
3	Apolipoproteins E (ApoE)IBA 01/2022 - 05/2015
3	Anticonvulsants (Antiepileptic Drugs)IBA 01/2020 - 06/2006
3	Levodopa (L Dopa)FDA LinkGeneric 10/2019 - 03/2012
3	alpha-SynucleinIBA 01/2019 - 03/2015
3	LipopolysaccharidesIBA 12/2018 - 10/2015
3	fallyprideIBA 02/2015 - 01/2013
3	Neurotransmitter Agents (Neurotransmitter)IBA 01/2015 - 02/2003
3	Serotonin (5 Hydroxytryptamine)IBA 08/2014 - 02/2003
3	salicylhydroxamic acid (SHAM)IBA 11/2012 - 04/2010
2	Somatostatin (Somatotropin Release-Inhibiting Factor)IBA 11/2023 - 10/2020
2	tau Proteins (tau Protein)IBA 01/2023 - 01/2023
2	7- (6- fluoropyridin- 3- yl)- 5H- pyrido(4,3- b)indoleIBA 01/2022 - 01/2020
2	flutemetamolIBA 01/2021 - 11/2015
2	AntigensIBA 01/2021 - 11/2011
2	CalciumIBA 01/2021 - 10/2020
2	Peptide Receptors (Peptide Receptor)IBA 10/2020 - 06/2020
2	Radioisotopes (Radionuclides)IBA 10/2020 - 06/2020
2	Metabotropic Glutamate Receptors (Metabotropic Glutamate Receptor)IBA 01/2018 - 01/2018
2	2- oxo- 7- methoxy- 8- butyloxy- 1,2- dihydroquinoline- 3- carboxylic acid cyclohexylamideIBA 11/2016 - 08/2013
2	CationsIBA 04/2013 - 01/2013
2	AD 20 (AD-20)IBA 01/2013 - 09/2010
2	2- (4'- (methylamino)phenyl)- 6- hydroxybenzothiazole (Pittsburgh compound B)IBA 01/2013 - 08/2009
2	Pilocarpine (Ocusert)FDA LinkGeneric 05/2009 - 06/2007
2	Neuroprotective AgentsIBA 02/2007 - 06/2006
2	Ciprofloxacin (Cipro)FDA LinkGeneric 03/2004 - 02/2004
1	GlucocorticoidsIBA 03/2024

Therapy/Procedure

14	Therapeutics 12/2023 - 01/2005
4	Drug Therapy (Chemotherapy) 04/2022 - 03/2007
3	Electrodes (Electrode) 12/2013 - 12/2003
3	Vagus Nerve Stimulation 12/2008 - 12/2005
2	Anesthesia 02/2017 - 12/2013
2	Gastric Balloon 01/2017 - 10/2013
2	Deep Brain Stimulation 06/2014 - 12/2003